Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Search Product Recalls

Try:····

Filters

Category

All Categories Food Medication Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Severity

All Severities Class I (High Risk)Class II (Moderate)Class III (Low)

Source

All Sources FDA CPSC USDA NHTSA

Status

Include terminated recalls

Clear all filters

Showing 681–700 of 1571 results

Sort:

Newest first Oldest first

Dianeal Low Calcium Dialysis Solution (Baxter) – Sterility Risk (2024)

Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.

Class IIModerate

FDAJun 17, 2024Nationwide• Baxter Healthcare Corporation

Zilretta (Pacira) – Dissolution Specifications (2024)

Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C

Class IIModerate

FDAJun 12, 2024Nationwide• PACIRA PHARMACEUTICALS INC

Eszopiclone Tablets (Dr. Reddy's) – Impurity Specifications (2024)

Failed Impurities/Degradation Specifications: Related Substances

FDAJun 4, 2024MS, OH• Dr. Reddy's Laboratories, Inc.

Amoxicillin Chewable Tablets (Teva) – Subpotent Drug (2024)

Subpotent Drug

Class IIModerate

FDAJun 4, 2024Nationwide• Teva Pharmaceuticals USA, Inc

Potassium Chloride Capsules (Glenmark) – CGMP Deviations (2024)

CGMP Deviations

Class IIModerate

FDAMay 30, 2024Nationwide• Glenmark Pharmaceuticals Inc., USA

Potassium Chloride Capsules (Glenmark) – Dissolution Failed (2024)

Failed Dissolution Specifications

FDAMay 30, 2024Nationwide• Glenmark Pharmaceuticals Inc., USA

Potassium Chloride Capsules (Glenmark) – CGMP Deviations (2024)

CGMP Deviations

Class IIModerate

FDAMay 30, 2024Nationwide• Glenmark Pharmaceuticals Inc., USA

Potassium Chloride Capsules (Glenmark) – Dissolution Failed (2024)

Failed Dissolution Specifications

FDAMay 30, 2024Nationwide• Glenmark Pharmaceuticals Inc., USA

Asmanex Twisthaler (Organon) – Defective Container (2024)

Defective Container

FDAMay 28, 2024Nationwide• Organon Llc

Asmanex Twisthaler (Organon) – Defective Container (2024)

Defective Container

FDAMay 28, 2024Nationwide• Organon Llc

Asmanex Twisthaler (Organon) – Defective Container (2024)

Defective Container

FDAMay 28, 2024Nationwide• Organon Llc

Docetaxel Injection (Sagent) – Particulate Matter (2024)

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

FDAMay 28, 2024Nationwide• Sagent Pharmaceuticals

Docetaxel Injection (Sagent) – Particulate Matter (2024)

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

FDAMay 28, 2024Nationwide• Sagent Pharmaceuticals

Dexamethasone Injection (Eugia) – Impurity Specifications (2024)

Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Class IIModerate

FDAMay 23, 2024Nationwide• Eugia US LLC

Zoledronic Acid Injection (Dr. Reddy's) – Sterility Concern (2024)

Lack of Assurance of Sterility: Leaking vials

Class IIModerate

FDAMay 23, 2024Nationwide• Dr. Reddy's Laboratories, Inc.

Eptifibatide Injection (Eugia) – Impurity Specifications (2024)

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

FDAMay 22, 2024Nationwide• Eugia US LLC

Acetaminophen Tablets (Contract Pharmacal) – Tablet Discoloration (2024)

Discoloration: Brownish tablets

Class IIModerate

FDAMay 20, 2024MI• Contract Pharmacal Corporation

Buprenorphine Hydrochloride Injection (Pfizer) – Crimp Seal Issue (2024)

Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Class IIModerate

FDAMay 20, 2024Nationwide• Pfizer Inc.

Labetalol Hydrochloride Injection (Pfizer) – Crimp Seal Issue (2024)

Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Class IIModerate

FDAMay 20, 2024Nationwide• Pfizer Inc.

Pregabalin Capsules (Rising Pharma) – Foreign Tablet Found (2024)

Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.

FDAMay 16, 2024Nationwide• Rising Pharma Holding, Inc.

1...33 343536 37...79

Page 35 of 79Next